Status:
COMPLETED
Randomized Controlled Trial of Citizen-targeted Evidence-based Resources
Lead Sponsor:
McMaster University
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Inflammatory Bowel Diseases
Irritable Bowel Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether an online resource developed to aid health consumers in making health decisions and better support them to seek quality evidence before other evidence...
Detailed Description
Participants who consent to participate in the study will be randomly allocated to either the intervention or control group. Once logged into the website, participants in the intervention group will ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients, caregivers or family members
- Aged 18 and above
- Have lived experience with, and are seeking information about, any of inflammatory bowel disease (i.e. Crohn's disease and ulcerative colitis), or irritable bowel syndrome
- The study may also include, but will not initial target/recruit, patients, caregivers or family members, aged 18 and above, who have lived experience with, and are seeking information about all other gastrointestinal conditions and their symptoms (including abdominal pain, bloating, constipation, cramping, diarrhea, fatigue, gas, loss of appetite, nausea, and stools with mucus), microbiome and metabolomics, and celiac disease.
Exclusion
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 18 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04693780
Start Date
April 19 2021
End Date
October 18 2021
Last Update
March 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McMaster Health Forum Impact Lab
Hamilton, Ontario, Canada, L8S 4K1